| 今开：7.4 | 昨收：7.42 |
| 最高：7.71 | 最低：7.32 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：4.1443912E8 |
Voyager Therapeutics(VYGR)01-30 06:35
$Voyager Therapeutics(VYGR)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-005550 Act: 34 Size: 13 KB 网页链接查看全文
Voyager Therapeutics(VYGR)02-14 06:25
$Voyager Therapeutics(VYGR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-022267 Act: 34 Size: 13 KB 网页链接查看全文
Voyager Therapeutics(VYGR)04-04 04:25
$Voyager Therapeutics(VYGR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043111 Size: 5 KB 网页链接查看全文
Voyager Therapeutics(VYGR)02-29 05:05
$Voyager Therapeutics(VYGR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-001987 Act: 34 Size: 354 KB 网页链接查看全文
Voyager Therapeutics(VYGR)02-29 06:26
$Voyager Therapeutics(VYGR)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-24-001988 Act: 34 Size: 13 MB 网页链接查看全文
Voyager Therapeutics(VYGR)03-27 05:35
$Voyager Therapeutics(VYGR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-039117 Size: 6 KB 网页链接查看全文
Voyager Therapeutics(VYGR)02-17 06:05
$Voyager Therapeutics(VYGR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-024989 Size: 8 KB 网页链接查看全文
Voyager Therapeutics(VYGR)02-22 04:15
$Voyager Therapeutics(VYGR)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-001230 Act: 33 Size: 5 KB 网页链接查看全文
Voyager Therapeutics(VYGR)02-21 04:15
$Voyager Therapeutics(VYGR)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-001160 Act: 33 Size: 4 KB 网页链接查看全文
Voyager Therapeutics(VYGR)02-23 05:45
$Voyager Therapeutics(VYGR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-026561 Size: 5 KB 网页链接查看全文
来源：格隆汇 基因疗法研究公司Voyager Therapeutics(VYGR.US)大涨25%，报10.55美元。Voyager Therapeutics周二称，诺华将支付1亿美元的预付款，作为开发基因疗法候选药物许可协议的一部分。该公司将向诺华公司... 网页链接
智通财经APP获悉，周二，基因疗法开发商Voyager Therapeutics(VYGR.US)与诺华制药(NVS.US)子公司达成战略合作和许可协议，以推进亨廷顿病(HD)和脊髓性肌萎缩症(SMA)的新型基因疗法。受此消息提振，截至发稿，Voyager Therapeutics周二... 网页链接
Voyager Therapeutics大涨60%，此前宣布与辉瑞达成腺病毒相关药物授权协议，公司将获得3000万美元预付额。 网页链接
$Voyager Therapeutics(VYGR)$ DEF 14A Other definitive proxy statements Accession Number: 0001558370-24-005793 Act: 34 Size: 1 MB 网页链接
$Voyager Therapeutics(VYGR)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001558370-24-005794 Act: 34 Size: 432 KB 网页链接
$Voyager Therapeutics(VYGR)$ ARS Annual Report to Security Holders Accession Number: 0001558370-24-005796 Act: 34 Size: 4 MB 网页链接
$Voyager Therapeutics(VYGR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043111 Size: 5 KB 网页链接
$Voyager Therapeutics(VYGR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043104 Size: 5 KB 网页链接
$Voyager Therapeutics(VYGR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-043107 Size: 5 KB 网页链接
$Voyager Therapeutics(VYGR)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001104659-24-042502 Act: 34 Size: 308 KB 网页链接
$Voyager Therapeutics(VYGR)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-002752 Act: 33 Size: 5 KB 网页链接
$Voyager Therapeutics(VYGR)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-002748 Act: 33 Size: 5 KB 网页链接
$Voyager Therapeutics(VYGR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-039117 Size: 6 KB 网页链接